The U.S. generic abortion pill manufacturer controlling roughly two-thirds of the abortion pill market has filed a motion to intervene in a lawsuit that is challenging the expansion of the abortion pill. The company says the outcome of the case could cause “serious harm” to its “economic interests.”
GenBioPro, according to a court document, is the “sole supplier of generic mifepristone in the United States,” an…
Generic abortion pill’s manufacturer files motion to protect its ‘economic interests’ in lawsuit
April 16, 2025